Toll-like receptor interactions:: tolerance of MyD88-dependent cytokines but enhancement of MyD88-independent interferon-β production

被引:102
作者
Broad, Andrea [1 ]
Kirby, John A. [1 ]
Jones, David E. J. [1 ]
机构
[1] Univ Newcastle Upon Tyne, Sch Med, Newcastle Upon Tyne NE2 4BY, Tyne & Wear, England
关键词
endotoxin tolerance; intracellular signalling; J774.2; pattern recognition receptors; RAW264.7;
D O I
10.1111/j.1365-2567.2006.02485.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-like receptors (TLRs) signal through two main pathways: a myeloid differentiation factor (MyD)88-dependent pathway that acts via nuclear factor kappa B (NF-kappa B) to induce proinflammatory cytokines such as tumour necrosis factor-alpha (TNF-alpha) and a MyD88-independent pathway that acts via type I interferons to increase the expression of interferon-inducible genes. Repeated signalling through TLR4 and a number of other TLRs has been reported to result in a reduction in the subsequent proinflammatory cytokine response, a phenomenon known as TLR tolerance. In this study we have shown that, whilst NF-kappa B activation and production of TNF-alpha and interleukin-12 by murine RAW264.7 and J774.2 cells in response to stimulation by TLR4, -5, -7 or -9, was reduced by prior stimulation with TLR4, -5, -7 or -9 ligands, the primary stimulation of TLR3, which does not use the MyD88 pathway, did not reduce the TNF-alpha or interleukin-12 responses to subsequent TLR stimulation. The response to TLR3 stimulation was not diminished by prior TLR ligand exposure. Furthermore, the production of interferon-beta (IFN-beta) following stimulation of TLR3 or -4, which is MyD88-independent, was increased by prior activation of TLR4, -5, -7 or -9. In contrast, TLR9 ligand-induced IFN-beta production, which is MyD88-dependent, was tolerized by prior TLR stimulation. These results are consistent with differential regulation of MyD88-dependent and MyD88-independent cytokine production following serial activation of TLRs.
引用
收藏
页码:103 / 111
页数:9
相关论文
共 51 条
[1]   TLR signaling in the gut in health and disease [J].
Abreu, MT ;
Fukata, M ;
Arditi, M .
JOURNAL OF IMMUNOLOGY, 2005, 174 (08) :4453-4460
[2]   Toll-like receptor signalling [J].
Akira, S ;
Takeda, K .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) :499-511
[3]   Interleukin-1β induces in vivo tolerance to lipopolysaccharide in mice [J].
Alves-Rosa, F ;
Vulcano, M ;
Beigier-Bompadre, M ;
Fernández, G ;
Palermo, M ;
Isturiz, MA .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 128 (02) :221-228
[4]   The induction of Toll-like receptor tolerance enhances rather than suppresses HIV-1 gene expression in transgenic mice [J].
Báfica, A ;
Scanga, CA ;
Equils, O ;
Sher, A .
JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 75 (03) :460-466
[5]   Acquired hyporesponsiveness to bacterial lipopolysaccharide and interferon-gamma in raw 264.7 macrophages [J].
Boyte, WR ;
Meals, EA ;
English, BK .
SHOCK, 1996, 6 (03) :218-222
[6]   Rip1 mediates the Trif-dependent Toll-like receptor 3- and 4-induced NF-κB activation but does not contribute to interferon regulatory factor 3 activation [J].
Cusson-Hermance, N ;
Khurana, S ;
Lee, TH ;
Fitzgerald, KA ;
Kelliher, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (44) :36560-36566
[7]   Induction of in vitro reprogramming by toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages:: Effects of TLR "homotolerance" versus "heterotolerance" on NF-κB signaling pathway components [J].
Dobrovolskaia, MA ;
Medvedev, AE ;
Thomas, KE ;
Cuesta, N ;
Toshchakov, V ;
Ren, TB ;
Cody, MJ ;
Michalek, SM ;
Rice, NR ;
Vogel, SN .
JOURNAL OF IMMUNOLOGY, 2003, 170 (01) :508-519
[8]  
DUNNE A, 2003, SCI STKE, V171, P3
[9]   Adenovirus infection dramatically augments lipopolysaccharide-induced TNF production and sensitizes to lethal shock [J].
Fejér, G ;
Szalay, K ;
Gyory, I ;
Fejes, M ;
Kúsz, E ;
Nedieanu, S ;
Páli, T ;
Schmidt, T ;
Siklódi, B ;
Lazar, G ;
Lazar, G ;
Duda, E .
JOURNAL OF IMMUNOLOGY, 2005, 175 (03) :1498-1506
[10]   LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF [J].
Fitzgerald, KA ;
Rowe, DC ;
Barnes, BJ ;
Caffrey, DR ;
Visintin, A ;
Latz, E ;
Monks, B ;
Pitha, PM ;
Golenbock, DT .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (07) :1043-1055